본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4 Choi Won Young
(Cancer Molecular Biology Branch)

Kang Min Chae
(Targeted Therapy Branch)
. Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4. FRONTIERS IN ONCOLOGY. 2024-10-08; 2024; 14:~. IF 3.5 (2023)
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study Han Ji-Youn
(Anticancer Resistance Branch )

Han Ji-Youn
(Anticancer Resistance Branch )
. Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study. BMC MEDICINE. 2024-10-08; 2024; 22:428~. IF 7.1 (2023)
RhoBTB3 Functions as a Novel Regulator of Autophagy by Suppressing AMBRA1 Stability Kim Youn Jae
(Targeted Therapy Branch)

KIM KYUNG HO
(Targeted Therapy Branch)
. RhoBTB3 Functions as a Novel Regulator of Autophagy by Suppressing AMBRA1 Stability. CELLS. 2024-10-07; 2024; 13(19):1659~. IF 5.1 (2023)
Development and cross-validation of prediction equations for body composition in adult cancer survivors from the Korean National Health and Nutrition Examination Survey (KNHANES) Choi Jinyoung
(National Hospice Center)

Kim Kyuwoong
(Hospice Care Quality & Education Team)
. Development and cross-validation of prediction equations for body composition in adult cancer survivors from the Korean National Health and Nutrition Examination Survey (KNHANES). PLOS ONE. 2024-10-04; 2024; 19(10:e0309061~. IF 2.9 (2023)
The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability
()

Kim Woo Rim
(Hospice Policy & Planning Team)
. The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability. JOURNAL OF PUBLIC HEALTH. 2024-10-03; 2024; 46(4):537~543. IF 3.6 (2023)
Cardiovascular Outcomes Associated With Isolated Systolic or Diastolic Hypertension According to the 2017 AHA/ACC Guideline in Adult Cancer Survivors Kim Kyuwoong
(Hospice Care Quality & Education Team)


()
. Cardiovascular Outcomes Associated With Isolated Systolic or Diastolic Hypertension According to the 2017 AHA/ACC Guideline in Adult Cancer Survivors. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024-09-30; 2024; 13(19):~. IF 5 (2023)
Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016 Cha Hyo Soung
(Data Planning & Technology Team)

Lee Sang Won
(Data Curation & Construction Team)
. Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016. SCIENTIFIC REPORTS. 2024-09-29; 2024; 14:22585~. IF 3.8 (2023)
Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer Kang Sokbom
(Division of Clinical Research)


()
. Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer. LUNG CANCER. 2024-09-28; 2024; 197:107970~. IF 4.5 (2023)
Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis Sun-Young Kong
(Targeted Therapy Branch)


()
. Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. CANCERS. 2024-09-28; 2024; 16(19):3318~. IF 4.5 (2023)
Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)

Thao Thi Kim TRINH
(Department of Cancer Control and Population Health)
. Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies. CANCER INVESTIGATION. 2024-09-26; 2024; 42(9):782~792. IF 1.8 (2023)